Erratum: A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth (Cancer Research (2005) 65 (4827–4835) DOI: 10.1158/0008-5472.CAN-05-0188)

Jen Liang Su, Kuo Pao Lai, Chi An Chen, Ching Yao Yang, Pei Sheng Chen, Chiao Chia Chang, Chia Hung Chou, Chi Lun Hu, Min Liang Kuo, Chang Yao Hsieh, Lin Hung Wei

Research output: Contribution to journalComment/debate

Abstract

The editors were made aware of concerns regarding potential manipulation of data in this article (1). An internal review by the editors determined that in Fig. 3A, the P-ERK Western blot bands in lanes 3 and 4 appear to be spliced together. In addition, the same Western blot image appears to have been used in Fig. 3C (STAT3) and Fig. 6B (b-actin). Because satisfactorily corrected figures could not be provided, the editors are publishing this note to alert readers to these concerns.

Original languageEnglish
Number of pages1
JournalCancer Research
Volume79
Issue number14
DOIs
Publication statusPublished - 2019 Jan 1

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum: A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth (Cancer Research (2005) 65 (4827–4835) DOI: 10.1158/0008-5472.CAN-05-0188)'. Together they form a unique fingerprint.

  • Cite this